United States Biotechnology & Medical Research

Kite Pharma Inc (KITE)

Track

Ticker: KITE Exchange: NSQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
MOORE TIMOTHY L.
EVP, Technical Operations
1 sale — total 759,619 USD
Sale 25 Sep 2017
Value US$1,211,796.55 | Price 436.49 | Shares 12,365
Sale 25 Sep 2017
Value US$2,690,468.16 | Price 403.47 | Shares 37,256
Sale 25 Sep 2017
Value US$170,321.38 | Price 179.66 | Shares 948
Sale 25 Sep 2017
Value US$759,618.97 | Price 179.66 | Shares 4,228
Sale 25 Sep 2017
Value US$4,733,604.77 | Price 179.66 | Shares 26,347
Sale 25 Sep 2017
Value US$569,714.23 | Price 179.66 | Shares 3,171
Sale 25 Sep 2017
Value US$755,127.37 | Price 179.66 | Shares 4,203
Sale 25 Sep 2017
Value US$1,424,195.74 | Price 179.66 | Shares 7,927
Planned sale 10 Aug 2017
Value US$701,974.00 | Price 121.03 | Shares 5,800
Planned sale 10 Aug 2017
Value US$1,108,784.00 | Price 120.52 | Shares 9,200
Planned sale 10 Aug 2017
Value US$750,682.59 | Price 120.09 | Shares 6,251
Planned sale 8 Aug 2017
Value US$1,611,065.38 | Price 121.37 | Shares 13,274
Planned sale 8 Aug 2017
Value US$3,752,266.00 | Price 120.40 | Shares 31,165
Planned sale 8 Aug 2017
Value US$2,271,183.84 | Price 119.94 | Shares 18,936
Planned sale 8 Aug 2017
Value US$450,718.00 | Price 118.61 | Shares 3,800
Planned sale 8 Aug 2017
Value US$199,359.00 | Price 117.27 | Shares 1,700
Planned sale 8 Aug 2017
Value US$1,273,731.48 | Price 115.02 | Shares 11,074
Planned sale 3 Aug 2017
Value US$564,666.55 | Price 110.05 | Shares 5,131
Planned sale 3 Aug 2017
Value US$95,676.90 | Price 110.10 | Shares 869
Planned sale 1 Aug 2017
Value US$35,101.35 | Price 109.35 | Shares 321
Planned sale 1 Aug 2017
Value US$408,286.17 | Price 108.27 | Shares 3,771
Planned sale 1 Aug 2017
Value US$584,266.98 | Price 107.58 | Shares 5,431
Planned sale 1 Aug 2017
Value US$264,667.45 | Price 106.85 | Shares 2,477
Planned sale 31 Jul 2017
Value US$74,995.20 | Price 111.60 | Shares 672
Planned sale 31 Jul 2017
Value US$301,248.75 | Price 110.55 | Shares 2,725
Planned sale 31 Jul 2017
Value US$817,343.52 | Price 109.74 | Shares 7,448
Planned sale 31 Jul 2017
Value US$1,718,685.00 | Price 108.75 | Shares 15,804
Planned sale 10 Jul 2017
Value US$527,500.00 | Price 105.50 | Shares 5,000
Planned sale 10 Jul 2017
Value US$113,091.00 | Price 102.81 | Shares 1,100
Planned sale 10 Jul 2017
Value US$567,461.07 | Price 102.19 | Shares 5,553
Planned sale 10 Jul 2017
Value US$338,247.82 | Price 101.06 | Shares 3,347
Planned sale 3 Jul 2017
Value US$125,816.76 | Price 104.76 | Shares 1,201
Planned sale 3 Jul 2017
Value US$917,383.74 | Price 104.26 | Shares 8,799
Sale 26 Jun 2017
Value US$1,257,500.00 | Price 100.60 | Shares 12,500
Planned sale 23 Jun 2017
Value US$207,439.50 | Price 101.19 | Shares 2,050
Planned sale 23 Jun 2017
Value US$296,593.00 | Price 100.54 | Shares 2,950
Planned sale 23 Jun 2017
Value US$1,250,000.00 | Price 100.00 | Shares 12,500
Sale 16 Jun 2017
Value US$480,199.50 | Price 88.11 | Shares 5,450
Sale 14 Jun 2017
Value US$1,356,000.00 | Price 90.40 | Shares 15,000
Sale 14 Jun 2017
Value US$1,789,574.00 | Price 89.48 | Shares 20,000
Planned sale 9 Jun 2017
Value US$36,432.00 | Price 91.08 | Shares 400
Planned sale 9 Jun 2017
Value US$152,412.48 | Price 89.76 | Shares 1,698
Planned sale 9 Jun 2017
Value US$365,269.00 | Price 89.09 | Shares 4,100
Planned sale 9 Jun 2017
Value US$219,675.60 | Price 87.80 | Shares 2,502
Planned sale 9 Jun 2017
Value US$77,778.00 | Price 86.42 | Shares 900
Planned sale 9 Jun 2017
Value US$33,924.00 | Price 84.81 | Shares 400
Sale 8 Jun 2017
Value US$422,634.00 | Price 84.53 | Shares 5,000
Sale 7 Jun 2017
Value US$844,621.00 | Price 84.46 | Shares 10,000
Planned sale 1 Jun 2017
Value US$173,880.00 | Price 72.45 | Shares 2,400
Buy 10 May 2017
Value US$217,770.00 | Price 72.59 | Shares 3,000
Planned buy 10 May 2017
Value US$32,656.50 | Price 72.57 | Shares 450
Buy 9 May 2017
Value US$181,450.08 | Price 68.94 | Shares 2,632
Buy 9 May 2017
Value US$71,175.93 | Price 69.17 | Shares 1,029
Buy 9 May 2017
Value US$183,369.67 | Price 69.17 | Shares 2,651
Buy 9 May 2017
Value US$243,478.40 | Price 69.17 | Shares 3,520
Buy 9 May 2017
Value US$97,300.00 | Price 69.50 | Shares 1,400
Buy 9 May 2017
Value US$1,165,690.00 | Price 68.57 | Shares 17,000
Buy 9 May 2017
Value US$267,622.25 | Price 70.15 | Shares 3,815
Buy 9 May 2017
Value US$3,179,375.40 | Price 68.84 | Shares 46,185
Planned sale 1 May 2017
Value US$25,008.00 | Price 83.36 | Shares 300
Planned sale 1 May 2017
Value US$487,753.00 | Price 82.60 | Shares 5,905
Planned sale 1 May 2017
Value US$1,128,982.80 | Price 81.84 | Shares 13,795
Planned sale 1 May 2017
Value US$197,088.00 | Price 82.12 | Shares 2,400
Sale 28 Apr 2017
Value US$216,138.03 | Price 82.59 | Shares 2,617
Sale 27 Apr 2017
Value US$1,369,926.27 | Price 82.77 | Shares 16,551
Sale 26 Apr 2017
Value US$16,612.00 | Price 83.06 | Shares 200
Sale 26 Apr 2017
Value US$4,227,984.64 | Price 82.72 | Shares 51,112
Planned sale 25 Apr 2017
Value US$310,099.54 | Price 82.87 | Shares 3,742
Planned sale 25 Apr 2017
Value US$455,466.30 | Price 82.14 | Shares 5,545
Planned sale 25 Apr 2017
Value US$462,124.57 | Price 80.89 | Shares 5,713
Sale 25 Apr 2017
Value US$1,275,669.64 | Price 83.29 | Shares 15,316
Sale 25 Apr 2017
Value US$2,597,915.52 | Price 82.56 | Shares 31,467
Sale 24 Apr 2017
Value US$2,125,854.12 | Price 82.34 | Shares 25,818
Sale 17 Apr 2017
Value US$8,306.00 | Price 83.06 | Shares 100
Sale 17 Apr 2017
Value US$3,546,722.48 | Price 82.48 | Shares 43,001
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2017-09-27 2017-09-25 S Sale MOORE TIMOTHY L.

EVP, Technical Operations
12,365 +23.4%
436.49
US$1,211,797 		12,365 +23.4% 436.49 US$1,211,797
2017-09-27 2017-09-25 S Sale Wiezorek Jeffrey

SVP Clinical Development
37,256 +14.0%
403.47
US$2,690,468 		37,256 +14.0% 403.47 US$2,690,468
2017-09-27 2017-09-25 S Sale JENKINSON PAUL L

Chief Financial Officer
8,562 +42.9%
84.53
US$2,966,991 		8,562 +42.9% 84.53 US$2,966,991
2017-09-27 2017-09-25 S Sale BUTITTA CYNTHIA M

Chief Operating Officer
4,228 -3.4%
179.66
US$759,619 		4,228 -3.4% 179.66 US$759,619
2017-09-27 2017-09-25 S Sale Belldegrun Arie

Chairman, President and CEO

Executive Director
26,347 -19.4%
179.66
US$4,733,605 		26,347 -19.4% 179.66 US$4,733,605
2017-09-27 2017-09-25 S Sale Kim Helen Susan

EVP, Business Development
3,171 -12.8%
179.66
US$569,714 		3,171 -12.8% 179.66 US$569,714
2017-09-27 2017-09-25 S Sale Tomasello Shawn

Chief Commercial Officer
4,203 -6.4%
179.66
US$755,127 		4,203 -6.4% 179.66 US$755,127
2017-09-27 2017-09-25 S Sale Chang David D

EVP, R&D, Chief Medical Off.
7,927 -12.1%
179.66
US$1,424,196 		7,927 -12.1% 179.66 US$1,424,196
2017-08-14 2017-08-10 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer
5,800 -4.7%
121.03
US$701,974 		5,800 -4.7% 121.03 US$701,974
2017-08-14 2017-08-10 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer
9,200 -6.9%
120.52
US$1,108,784 		9,200 -6.9% 120.52 US$1,108,784
2017-08-14 2017-08-10 PlS Planned sale Kim Helen Susan

EVP, Business Development
6,251 -25.1%
120.09
US$750,683 		6,251 -25.1% 120.09 US$750,683
2017-08-10 2017-08-08 PlS Planned sale Kim Helen Susan

EVP, Business Development
13,274 -41.6%
121.37
US$1,611,065 		13,274 -41.6% 121.37 US$1,611,065
2017-08-10 2017-08-08 PlS Planned sale Kim Helen Susan

EVP, Business Development
31,165 -49.4%
120.40
US$3,752,266 		31,165 -49.4% 120.40 US$3,752,266
2017-08-10 2017-08-08 PlS Planned sale Kim Helen Susan

EVP, Business Development
18,936 -23.1%
119.94
US$2,271,184 		18,936 -23.1% 119.94 US$2,271,184
2017-08-10 2017-08-08 PlS Planned sale Kim Helen Susan

EVP, Business Development
3,800 -4.4%
118.61
US$450,718 		3,800 -4.4% 118.61 US$450,718
2017-08-10 2017-08-08 PlS Planned sale Kim Helen Susan

EVP, Business Development
1,700 -1.9%
117.27
US$199,359 		1,700 -1.9% 117.27 US$199,359
2017-08-10 2017-08-08 PlS Planned sale Kim Helen Susan

EVP, Business Development
11,074 -11.2%
115.02
US$1,273,731 		11,074 -11.2% 115.02 US$1,273,731
2017-08-04 2017-08-03 PlS Planned sale MOORE TIMOTHY L.

EVP, Technical Operations
5,131 -9.4%
110.05
US$564,667 		5,131 -9.4% 110.05 US$564,667
2017-08-04 2017-08-03 PlS Planned sale MOORE TIMOTHY L.

EVP, Technical Operations
869 -1.6%
110.10
US$95,677 		869 -1.6% 110.10 US$95,677
2017-08-03 2017-08-01 PlS Planned sale MOORE TIMOTHY L.

EVP, Technical Operations
321 -0.6%
109.35
US$35,101 		321 -0.6% 109.35 US$35,101
2017-08-03 2017-08-01 PlS Planned sale MOORE TIMOTHY L.

EVP, Technical Operations
3,771 -7.0%
108.27
US$408,286 		3,771 -7.0% 108.27 US$408,286
2017-08-03 2017-08-01 PlS Planned sale MOORE TIMOTHY L.

EVP, Technical Operations
5,431 -9.2%
107.58
US$584,267 		5,431 -9.2% 107.58 US$584,267
2017-08-03 2017-08-01 PlS Planned sale MOORE TIMOTHY L.

EVP, Technical Operations
2,477 -4.0%
106.85
US$264,667 		2,477 -4.0% 106.85 US$264,667
2017-08-01 2017-07-31 PlS Planned sale Kim Helen Susan

EVP, Business Development
672 -3.5%
111.60
US$74,995 		672 -3.5% 111.60 US$74,995
2017-08-01 2017-07-31 PlS Planned sale Kim Helen Susan

EVP, Business Development
2,725 -12.4%
110.55
US$301,249 		2,725 -12.4% 110.55 US$301,249
2017-08-01 2017-07-31 PlS Planned sale Kim Helen Susan

EVP, Business Development
7,448 -25.2%
109.74
US$817,344 		7,448 -25.2% 109.74 US$817,344
2017-08-01 2017-07-31 PlS Planned sale Kim Helen Susan

EVP, Business Development
15,804 -34.9%
108.75
US$1,718,685 		15,804 -34.9% 108.75 US$1,718,685
2017-07-11 2017-07-10 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer

Officer
5,000 -4.1%
105.50
US$527,500 		5,000 -4.1% 105.50 US$527,500
2017-07-11 2017-07-10 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer

Officer
1,100 -0.9%
102.81
US$113,091 		1,100 -0.9% 102.81 US$113,091
2017-07-11 2017-07-10 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer

Officer
5,553 -4.3%
102.19
US$567,461 		5,553 -4.3% 102.19 US$567,461
2017-07-11 2017-07-10 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer

Officer
3,347 -2.5%
101.06
US$338,248 		3,347 -2.5% 101.06 US$338,248
2017-07-06 2017-07-03 PlS Planned sale Wiezorek Jeffrey

SVP Clinical Development

Officer
1,201 -5.4%
104.76
US$125,817 		1,201 -5.4% 104.76 US$125,817
2017-07-06 2017-07-03 PlS Planned sale Wiezorek Jeffrey

SVP Clinical Development

Officer
8,799 -28.3%
104.26
US$917,384 		8,799 -28.3% 104.26 US$917,384
2017-06-26 2017-06-26 S Sale WITTE OWEN N.
12,500 -14.1%
100.60
US$1,257,500 		12,500 -14.1% 100.60 US$1,257,500
2017-06-27 2017-06-23 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer
2,050 -1.8%
101.19
US$207,440 		2,050 -1.8% 101.19 US$207,440
2017-06-27 2017-06-23 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer
2,950 -2.5%
100.54
US$296,593 		2,950 -2.5% 100.54 US$296,593
2017-06-26 2017-06-23 PlS Planned sale WITTE OWEN N.
12,500 -12.3%
100.00
US$1,250,000 		12,500 -12.3% 100.00 US$1,250,000
2017-06-16 2017-06-16 S Sale CHAMPSI FARAH
5,450 -100.0%
88.11
US$480,200 		5,450 -100.0% 88.11 US$480,200
2017-06-16 2017-06-14 S Sale CHAMPSI FARAH
15,000 -19.1%
90.40
US$1,356,000 		15,000 -19.1% 90.40 US$1,356,000
2017-06-16 2017-06-14 S Sale Ruchefsky Steven B
20,000 -8.9%
89.48
US$1,789,574 		20,000 -8.9% 89.48 US$1,789,574
2017-06-12 2017-06-09 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer
400 -0.3%
91.08
US$36,432 		400 -0.3% 91.08 US$36,432
2017-06-12 2017-06-09 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer
1,698 -1.4%
89.76
US$152,412 		1,698 -1.4% 89.76 US$152,412
2017-06-12 2017-06-09 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer
4,100 -3.3%
89.09
US$365,269 		4,100 -3.3% 89.09 US$365,269
2017-06-12 2017-06-09 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer
2,502 -2.0%
87.80
US$219,676 		2,502 -2.0% 87.80 US$219,676
2017-06-12 2017-06-09 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer
900 -0.7%
86.42
US$77,778 		900 -0.7% 86.42 US$77,778
2017-06-12 2017-06-09 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer
400 -0.3%
84.81
US$33,924 		400 -0.3% 84.81 US$33,924
2017-06-09 2017-06-08 S Sale DOUMANI ROY
5,000 -3.2%
84.53
US$422,634 		5,000 -3.2% 84.53 US$422,634
2017-06-09 2017-06-07 S Sale DOUMANI ROY
10,000 -6.1%
84.46
US$844,621 		10,000 -6.1% 84.46 US$844,621
2017-06-05 2017-06-01 PlS Planned sale Kim Helen Susan

EVP, Business Development
2,400 -11.4%
72.45
US$173,880 		2,400 -11.4% 72.45 US$173,880
2017-05-10 2017-05-10 B Purchase JENKINSON PAUL L

Chief Financial Officer

Officer
3,000 +inf%
72.59
US$217,770 		3,000 +inf% 72.59 US$217,770
2017-05-10 2017-05-10 PP Planned purchase JENKINSON PAUL L

Chief Financial Officer

Officer
450 +6.4%
72.57
US$32,656 		450 +6.4% 72.57 US$32,656
2017-05-11 2017-05-09 B Purchase Nussbaum Ran Non-Executive Director
2,632 +inf%
68.94
US$181,450 		2,632 +inf% 68.94 US$181,450
2017-05-11 2017-05-09 B Purchase Nussbaum Ran Non-Executive Director
1,029 +inf%
69.17
US$71,176 		1,029 +inf% 69.17 US$71,176
2017-05-11 2017-05-09 B Purchase Nussbaum Ran Non-Executive Director
2,651 +inf%
69.17
US$183,370 		2,651 +inf% 69.17 US$183,370
2017-05-11 2017-05-09 B Purchase Nussbaum Ran Non-Executive Director
3,520 +inf%
69.17
US$243,478 		3,520 +inf% 69.17 US$243,478
2017-05-10 2017-05-09 B Purchase Ruchefsky Steven B Non-Executive Director
1,400 +0.6%
69.50
US$97,300 		1,400 +0.6% 69.50 US$97,300
2017-05-09 2017-05-09 B Purchase Belldegrun Arie

Chairman, President and CEO

Executive Director
17,000 +24.8%
68.57
US$1,165,690 		17,000 +24.8% 68.57 US$1,165,690
2017-05-09 2017-05-09 B Purchase BONDERMAN DAVID Non-Executive Director
3,815 +0.2%
70.15
US$267,622 		3,815 +0.2% 70.15 US$267,622
2017-05-09 2017-05-09 B Purchase BONDERMAN DAVID Non-Executive Director
46,185 +2.0%
68.84
US$3,179,375 		46,185 +2.0% 68.84 US$3,179,375
2017-05-03 2017-05-01 PlS Planned sale Chang David D

EVP, R&D, Chief Medical Off.

Officer
300 -0.6%
83.36
US$25,008 		300 -0.6% 83.36 US$25,008
2017-05-03 2017-05-01 PlS Planned sale Chang David D

EVP, R&D, Chief Medical Off.

Officer
5,905 -10.5%
82.60
US$487,753 		5,905 -10.5% 82.60 US$487,753
2017-05-03 2017-05-01 PlS Planned sale Chang David D

EVP, R&D, Chief Medical Off.

Officer
13,795 -19.7%
81.84
US$1,128,983 		13,795 -19.7% 81.84 US$1,128,983
2017-05-03 2017-05-01 PlS Planned sale Kim Helen Susan

EVP, Business Development

Officer
2,400 -11.4%
82.12
US$197,088 		2,400 -11.4% 82.12 US$197,088
2017-05-01 2017-04-28 S Sale CHAMPSI FARAH Non-Executive Director
2,617 -34.5%
82.59
US$216,138 		2,617 -34.5% 82.59 US$216,138
2017-05-01 2017-04-27 S Sale CHAMPSI FARAH Non-Executive Director
16,551 -68.6%
82.77
US$1,369,926 		16,551 -68.6% 82.77 US$1,369,926
2017-04-26 2017-04-26 S Sale CHAMPSI FARAH
200 -0.8%
83.06
US$16,612 		200 -0.8% 83.06 US$16,612
2017-04-26 2017-04-26 S Sale CHAMPSI FARAH
51,112 -67.8%
82.72
US$4,227,985 		51,112 -67.8% 82.72 US$4,227,985
2017-04-27 2017-04-25 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer
3,742 -3.1%
82.87
US$310,100 		3,742 -3.1% 82.87 US$310,100
2017-04-27 2017-04-25 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer
5,545 -4.4%
82.14
US$455,466 		5,545 -4.4% 82.14 US$455,466
2017-04-27 2017-04-25 PlS Planned sale BUTITTA CYNTHIA M

Chief Operating Officer
5,713 -4.3%
80.89
US$462,125 		5,713 -4.3% 80.89 US$462,125
2017-04-26 2017-04-25 S Sale CHAMPSI FARAH
15,316 -16.9%
83.29
US$1,275,670 		15,316 -16.9% 83.29 US$1,275,670
2017-04-26 2017-04-25 S Sale CHAMPSI FARAH
31,467 -25.7%
82.56
US$2,597,916 		31,467 -25.7% 82.56 US$2,597,916
2017-04-26 2017-04-24 S Sale CHAMPSI FARAH
25,818 -17.4%
82.34
US$2,125,854 		25,818 -17.4% 82.34 US$2,125,854
2017-04-17 2017-04-17 S Sale CHAMPSI FARAH
100 -0.1%
83.06
US$8,306 		100 -0.1% 83.06 US$8,306
2017-04-17 2017-04-17 S Sale CHAMPSI FARAH
43,001 -22.5%
82.48
US$3,546,722 		43,001 -22.5% 82.48 US$3,546,722
Explore more

More insider trading research around Kite Pharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America